{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:56:45Z","timestamp":1793120205544,"version":"4.5.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40263-026-01298-5","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T12:07:41Z","timestamp":1782648461000},"page":"1101-1147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psychiatric Symptoms Associated with Corticosteroid\u00a0Use: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1633-9603","authenticated-orcid":false,"given":"Keisuke","family":"Kusudo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2121-7404","authenticated-orcid":false,"given":"Yuki","family":"Mashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5593-9506","authenticated-orcid":false,"given":"Hideaki","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9132-8940","authenticated-orcid":false,"given":"Teruomi","family":"Iyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-4786","authenticated-orcid":false,"given":"Hiroyoshi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"issue":"1","key":"1298_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000560","volume":"9","author":"K Molooghi","year":"2022","unstructured":"Molooghi K, Sheybani F, Naderi H, Mirfeizi Z, Morovatdar N, Baradaran A. Central nervous system infections in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus Sci Med. 2022;9(1):e000560. https:\/\/doi.org\/10.1136\/lupus-2021-000560.","journal-title":"Lupus Sci Med."},{"issue":"1","key":"1298_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/archdischild-2024-327523","volume":"110","author":"S Amagasa","year":"2025","unstructured":"Amagasa S, Utsumi S, Okajima K, Uematsu S. Oral systemic corticosteroids in children with acute asthma exacerbations: a systematic review and network meta-analysis. Arch Dis Child. 2025;110(1):15\u201322. https:\/\/doi.org\/10.1136\/archdischild-2024-327523.","journal-title":"Arch Dis Child"},{"issue":"1","key":"1298_CR3","doi-asserted-by":"publisher","first-page":"112070002513899","DOI":"10.1177\/11207000251389936","volume":"35","author":"A Zampoli","year":"2025","unstructured":"Zampoli A, Zampogna B, Papalia GF, Gentile G, Parisi FR, Giurazza G, et al. Outcomes and complications of total hip arthroplasty in patients affected by haematological disorder: a systematic review. Hip Int. 2025;35(1):11207000251389936. https:\/\/doi.org\/10.1177\/11207000251389936.","journal-title":"Hip Int"},{"issue":"1","key":"1298_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. https:\/\/doi.org\/10.1186\/1710-1492-9-30.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"1298_CR5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/npp.2012.249","volume":"38","author":"KD Sudheimer","year":"2013","unstructured":"Sudheimer KD, Abelson JL, Taylor SF, Martis B, Welsh RC, Warner C, et al. Exogenous glucocorticoids decrease subgenual cingulate activity evoked by sadness. Neuropsychopharmacology. 2013;38(5):826\u201345. https:\/\/doi.org\/10.1038\/npp.2012.249.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1298_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/npr2.12209","volume":"41","author":"Y Yagi","year":"2021","unstructured":"Yagi Y, Takahashi Y, Ogata Y, Yamana H, Kumakura Y, Ichihashi K, et al. Oral corticosteroid dosage and clinical presentation of psychiatric conditions after steroid use: a consultation-liaison psychiatry service\u2019s experience. Neuropsychopharmacol Rep. 2021;41(4):471\u20135. https:\/\/doi.org\/10.1002\/npr2.12209.","journal-title":"Neuropsychopharmacol Rep."},{"issue":"5","key":"1298_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","volume":"169","author":"L Fardet","year":"2012","unstructured":"Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012;169(5):491\u20137. https:\/\/doi.org\/10.1176\/appi.ajp.2011.11071009.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1298_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.psyneuen.2010.03.007","volume":"36","author":"C Anacker","year":"2011","unstructured":"Anacker C, Zunszain PA, Carvalho LA, Pariante CM. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology. 2011;36(3):415\u201325. https:\/\/doi.org\/10.1016\/j.psyneuen.2010.03.007.","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"1298_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/diseases12120300","volume":"12","author":"L Nasereddin","year":"2024","unstructured":"Nasereddin L, Alnajjar O, Bashar H, Abuarab SF, Al-Adwan R, Chellappan DK, et al. Corticosteroid-induced psychiatric disorders: mechanisms, outcomes, and clinical implications. Diseases. 2024;12(12):300. https:\/\/doi.org\/10.3390\/diseases12120300.","journal-title":"Diseases"},{"issue":"12","key":"1298_CR10","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1002\/hbm.21409","volume":"33","author":"MJAG Henckens","year":"2012","unstructured":"Henckens MJAG, Pu Z, Hermans EJ, van Wingen GA, Jo\u00ebls M, Fern\u00e1ndez G. Dynamically changing effects of corticosteroids on human hippocampal and prefrontal processing. Hum Brain Mapp. 2012;33(12):2885\u201397. https:\/\/doi.org\/10.1002\/hbm.21409.","journal-title":"Hum Brain Mapp"},{"key":"1298_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00003","volume":"9","author":"J Liu","year":"2018","unstructured":"Liu J, Mustafa S, Barratt DT, Hutchinson MR. Corticosterone preexposure increases NF-\u03baB translocation and sensitizes IL-1\u03b2 responses in BV2 microglia-like cells. Front Immunol. 2018;9:3. https:\/\/doi.org\/10.3389\/fimmu.2018.00003.","journal-title":"Front Immunol"},{"issue":"6","key":"1298_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1440-1819.2011.02260.x","volume":"65","author":"HA Kenna","year":"2011","unstructured":"Kenna HA, Poon AW, de los Angeles CP, Koran LM. Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci. 2011;65(6):549\u201360. https:\/\/doi.org\/10.1111\/j.1440-1819.2011.02260.x.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"6","key":"1298_CR13","doi-asserted-by":"publisher","first-page":"e1281","DOI":"10.1210\/clinem\/dgad701","volume":"109","author":"AS Koning","year":"2024","unstructured":"Koning AS, van der Meulen M, Schaap D, Satoer D, Vinkers CH, van Rossum EF, et al. Neuropsychiatric adverse effects of synthetic glucocorticoids: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2024;109(6):e1281\u201394. https:\/\/doi.org\/10.1210\/clinem\/dgad701.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1298_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/cpt1972135part1694","volume":"13","author":"Boston Collaborative Drug Surveillance Program","year":"1972","unstructured":"Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther. 1972;13(5):694\u20138. https:\/\/doi.org\/10.1002\/cpt1972135part1694.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"1298_CR15","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.4065\/81.10.1361","volume":"81","author":"TP Warrington","year":"2006","unstructured":"Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361\u20137. https:\/\/doi.org\/10.4065\/81.10.1361.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"1298_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092131","volume":"12","author":"S Avenda\u00f1o-Lopez","year":"2024","unstructured":"Avenda\u00f1o-Lopez S, Rodr\u00edguez-Mar\u00edn AJ, Lara-Castillo M, Agresott-Carrillo J, Lara-Cort\u00e9s LE, S\u00e1nchez-Almanzar JF, et al. Molecular, pathophysiological, and clinical aspects of corticosteroid-induced neuropsychiatric effects: from bench to bedside. Biomedicines. 2024;12(9):2131. https:\/\/doi.org\/10.3390\/biomedicines12092131.","journal-title":"Biomedicines"},{"issue":"1","key":"1298_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00004714-200202000-00009","volume":"22","author":"ES Brown","year":"2002","unstructured":"Brown ES, Suppes T, Khan DA, Carmody TJ 3rd. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol. 2002;22(1):55\u201361. https:\/\/doi.org\/10.1097\/00004714-200202000-00009.","journal-title":"J Clin Psychopharmacol"},{"key":"1298_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1628765","volume":"16","author":"S Gostoli","year":"2025","unstructured":"Gostoli S, Carrozzino D, Raimondi G, Subach R, Gigante G, Rafanelli C. Corticosteroid-induced manic and\/or psychotic symptoms: a systematic review. Front Pharmacol. 2025;16:1628765. https:\/\/doi.org\/10.3389\/fphar.2025.1628765.","journal-title":"Front Pharmacol"},{"key":"1298_CR19","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute. 2011. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 28 Apr 2026."},{"issue":"12","key":"1298_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamapsychiatry.2021.2506","volume":"78","author":"H Bode","year":"2021","unstructured":"Bode H, Ivens B, Bschor T, Schwarzer G, Henssler J, Baethge C. Association of hypothyroidism and clinical depression: a systematic review and meta-analysis. JAMA Psychiat. 2021;78(12):1375\u201383. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.2506.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"1298_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147601","volume":"11","author":"PA Modesti","year":"2016","unstructured":"Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, et al. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS ONE. 2016;11(1):e0147601. https:\/\/doi.org\/10.1371\/journal.pone.0147601.","journal-title":"PLoS ONE"},{"key":"1298_CR22","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A, editors. GRADE Handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group. 2013. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Accessed 28 Apr 2026."},{"issue":"4","key":"1298_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.10.001","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.10.001.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1298_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00296-007-0410-x","volume":"28","author":"S Appenzeller","year":"2008","unstructured":"Appenzeller S, Cendes F, Costallat LTL. Acute psychosis in systemic lupus erythematosus. Rheumatol Int. 2008;28(3):237\u201343. https:\/\/doi.org\/10.1007\/s00296-007-0410-x.","journal-title":"Rheumatol Int"},{"issue":"8","key":"1298_CR25","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00296-013-2750-z","volume":"33","author":"SD Bhangle","year":"2013","unstructured":"Bhangle SD, Kramer N, Rosenstein ED. Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus. Rheumatol Int. 2013;33(8):1923\u201332. https:\/\/doi.org\/10.1007\/s00296-013-2750-z.","journal-title":"Rheumatol Int"},{"issue":"6","key":"1298_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/archdischild-2024-327523","volume":"15","author":"A Mak","year":"2009","unstructured":"Mak A, Ho RCM, Lau CS. Clinical implications of neuropsychiatric systemic lupus erythematosus. Adv Psychiatr Treat. 2009;15(6):451\u20138.\u00a0https:\/\/doi.org\/10.1192\/apt.bp.108.005785.","journal-title":"Adv Psychiatr Treat"},{"issue":"1","key":"1298_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02885-6","volume":"20","author":"Y Sun","year":"2020","unstructured":"Sun Y, Fu Z, Bo Q, Mao Z, Ma X, Wang C. The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital. BMC Psychiatry. 2020;20(1):474. https:\/\/doi.org\/10.1186\/s12888-020-02885-6.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"1298_CR28","first-page":"OC01","volume":"18","author":"S Mishra","year":"2024","unstructured":"Mishra S, Saxena A, Mishra AK, Mishra N, Saad T, Prasad S. Correlation of duration of inhaled steroid use on psychological symptoms in COPD patients. J Clin Diagn Res. 2024;18(3):OC01-4.","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"1298_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/20018525.2022.2149920","volume":"10","author":"M Renzi-Lomholt","year":"2023","unstructured":"Renzi-Lomholt M, H\u00e5kansson KEJ, Suppli Ulrik C. Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma. Eur Clin Respir J. 2023;10(1):2149920. https:\/\/doi.org\/10.1080\/20018525.2022.2149920.","journal-title":"Eur Clin Respir J"},{"issue":"1","key":"1298_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02466-2","volume":"23","author":"Y Miyawaki","year":"2021","unstructured":"Miyawaki Y, Shimizu S, Ogawa Y, Sada KE, Katayama Y, Asano Y, et al. Association of glucocorticoid doses and emotional health in Lupus low disease activity state (LLDAS): a cross-sectional study. Arthritis Res Ther. 2021;23(1):79. https:\/\/doi.org\/10.1186\/s13075-021-02466-2.","journal-title":"Arthritis Res Ther"},{"issue":"3-4","key":"1298_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000501617","volume":"110","author":"M Savas","year":"2020","unstructured":"Savas M, Vinkers CH, Rosmalen JGM, Hartman CA, Wester VL, van den Akker ELT, et al. Systemic and local corticosteroid use is associated with reduced executive cognition, and mood and anxiety disorders. Neuroendocrinology. 2020;110(3\u20134):282\u201391. https:\/\/doi.org\/10.1159\/000501617.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"1298_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jaip.2020.08.032","volume":"9","author":"PJ McDowell","year":"2021","unstructured":"McDowell PJ, Stone JH, Zhang Y, Honeyford K, Dunn L, Logan RJ, et al. Quantification of glucocorticoid-associated morbidity in severe asthma using the glucocorticoid toxicity index. J Allergy Clin Immunol Pract. 2021;9(1):365-72.e5. https:\/\/doi.org\/10.1016\/j.jaip.2020.08.032.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"1298_CR33","first-page":"495","volume":"29","author":"M Czok","year":"2017","unstructured":"Czok M, \u0106wiek A, Kurczab B, Kramarczyk K. Association between affective disorders and the usage of low and medium doses of corticosteroids. Psychiatr Danub. 2017;29(4):495\u20138.","journal-title":"Psychiatr Danub"},{"issue":"13","key":"1298_CR34","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1177\/0961203316642313","volume":"25","author":"E Montero-L\u00f3pez","year":"2016","unstructured":"Montero-L\u00f3pez E, Santos-Ruiz A, Navarrete-Navarrete N, Ortego-Centeno N, P\u00e9rez-Garc\u00eda M, Peralta-Ram\u00edrez MI. The effects of corticosteroids on cognitive flexibility and decision-making in women with Lupus. Lupus. 2016;25(13):1470\u20138. https:\/\/doi.org\/10.1177\/0961203316642313.","journal-title":"Lupus"},{"issue":"6","key":"1298_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4103\/0378-6323.168324","volume":"81","author":"SM Singh","year":"2015","unstructured":"Singh SM, Narang T, Dogra S, Handa S. Self-perceived emotional side effects of systemic corticosteroid therapy in dermatology patients. Indian J Dermatol Venereol Leprol. 2015;81(6):655. https:\/\/doi.org\/10.4103\/0378-6323.168324.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"8","key":"1298_CR36","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/neuonc\/nov054","volume":"17","author":"TS Armstrong","year":"2015","unstructured":"Armstrong TS, Ying Y, Wu J, Acquaye AA, Vera-Bolanos E, Gilbert MR, et al. The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-Chronic. Neuro Oncol. 2015;17(8):1114\u201320. https:\/\/doi.org\/10.1093\/neuonc\/nov054.","journal-title":"Neuro Oncol"},{"issue":"3","key":"1298_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.rmed.2013.12.012","volume":"108","author":"M Amelink","year":"2014","unstructured":"Amelink M, Hashimoto S, Spinhoven P, Pasma HR, Sterk PJ, Bel EH, et al. Anxiety, depression and personality traits in severe, prednisone-dependent asthma. Respir Med. 2014;108(3):438\u201344. https:\/\/doi.org\/10.1016\/j.rmed.2013.12.012.","journal-title":"Respir Med"},{"issue":"5","key":"1298_CR38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1530\/EJE-12-0041","volume":"166","author":"RM Reynolds","year":"2012","unstructured":"Reynolds RM, Labad J, Sears AV, Williamson RM, Strachan MWJ, Deary IJ, et al. Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study. Eur J Endocrinol. 2012;166(5):861\u20138. https:\/\/doi.org\/10.1530\/EJE-12-0041.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1298_CR39","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10067-010-1651-8","volume":"30","author":"A Mak","year":"2011","unstructured":"Mak A, Tang CS-K, Chan M-F, Cheak AA-C, Ho RC-M. Damage accrual, cumulative glucocorticoid dose and depression predict anxiety in patients with systemic lupus erythematosus. Clin Rheumatol. 2011;30(6):795\u2013803. https:\/\/doi.org\/10.1007\/s10067-010-1651-8.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"1298_CR40","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.4088\/jcp.10m06765","volume":"72","author":"J-M Woo","year":"2011","unstructured":"Woo J-M, Gibbons RD, Qin P, Komarow H, Kim JB, Rogers CA, et al. Suicide and prescription rates of intranasal corticosteroids and nonsedating antihistamines for allergic rhinitis: an ecological study. J Clin Psychiatry. 2011;72(10):1423\u20138. https:\/\/doi.org\/10.4088\/jcp.10m06765.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"1298_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.eurpsy.2004.06.023","volume":"20","author":"B Sheng","year":"2005","unstructured":"Sheng B, Cheng SKW, Lau KK, Li HL, Chan ELY. The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases. Eur Psychiatry. 2005;20(3):236\u201342. https:\/\/doi.org\/10.1016\/j.eurpsy.2004.06.023.","journal-title":"Eur Psychiatry"},{"issue":"5","key":"1298_CR42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1467-9450.2005.00477.x","volume":"46","author":"E Romero-Frais","year":"2005","unstructured":"Romero-Frais E, V\u00e1zquez MI, S\u00e1ndez E, Blanco-Aparicio M, Otero I, Verea H. Prescription of oral corticosteroids in near-fatal asthma patients: relationship with panic-fear, anxiety and depression. Scand J Psychol. 2005;46(5):459\u201365. https:\/\/doi.org\/10.1111\/j.1467-9450.2005.00477.x.","journal-title":"Scand J Psychol"},{"issue":"5","key":"1298_CR43","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/s1081-1206(10)61756-5","volume":"92","author":"SH Bolanos","year":"2004","unstructured":"Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol. 2004;92(5):500\u20135. https:\/\/doi.org\/10.1016\/s1081-1206(10)61756-5.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"1298_CR44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1081\/jas-120023491","volume":"40","author":"SB Bonala","year":"2003","unstructured":"Bonala SB, Pina D, Silverman BA, Amara S, Bassett CW, Schneider AT. Asthma severity, psychiatric morbidity, and quality of life: correlation with inhaled corticosteroid dose. J Asthma. 2003;40(6):691\u20139. https:\/\/doi.org\/10.1081\/jas-120023491.","journal-title":"J Asthma"},{"issue":"2","key":"1298_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/comp.2001.21218","volume":"42","author":"SB Patten","year":"2001","unstructured":"Patten SB, Lavorato DH. Medication use and major depressive syndrome in a community population. Compr Psychiatry. 2001;42(2):124\u201331. https:\/\/doi.org\/10.1053\/comp.2001.21218.","journal-title":"Compr Psychiatry"},{"issue":"6","key":"1298_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/s0022-3999(00)00187-2","volume":"49","author":"SB Patten","year":"2000","unstructured":"Patten SB. Exogenous corticosteroids and major depression in the general population. J Psychosom Res. 2000;49(6):447\u20139. https:\/\/doi.org\/10.1016\/s0022-3999(00)00187-2.","journal-title":"J Psychosom Res"},{"issue":"3","key":"1298_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0020-7489(89)90009-6","volume":"26","author":"AG Gift","year":"1989","unstructured":"Gift AG, Wood RM, Cahill CA. Depression, somatization and steroid use in chronic obstructive pulmonary disease. Int J Nurs Stud. 1989;26(3):281\u20136. https:\/\/doi.org\/10.1016\/0020-7489(89)90009-6.","journal-title":"Int J Nurs Stud"},{"issue":"6","key":"1298_CR48","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1192\/bjp.138.6.504","volume":"138","author":"C Cordess","year":"1981","unstructured":"Cordess C, Folstein M, Drachman D. Psychiatric effects of alternate day steroid therapy. Br J Psychiatry. 1981;138(6):504\u20136. https:\/\/doi.org\/10.1192\/bjp.138.6.504.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"1298_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/s1355617712001014","volume":"19","author":"C Mrakotsky","year":"2013","unstructured":"Mrakotsky C, Forbes PW, Bernstein JH, Grand RJ, Bousvaros A, Szigethy E, et al. Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. J Int Neuropsychol Soc. 2013;19(1):96\u2013109. https:\/\/doi.org\/10.1017\/s1355617712001014.","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"1298_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3899\/jrheum.160214","volume":"45","author":"H-L Chen","year":"2018","unstructured":"Chen H-L, Shen L-J, Hsu P-N, Shen C-Y, Hall SA, Hsiao F-Y. Cumulative burden of glucocorticoid-related adverse events in patients with systemic lupus erythematosus: findings from a 12-year longitudinal study. J Rheumatol. 2018;45(1):83\u20139. https:\/\/doi.org\/10.3899\/jrheum.160214.","journal-title":"J Rheumatol"},{"key":"1298_CR51","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00415-016-8183-3","volume":"263","author":"PJ Jongen","year":"2016","unstructured":"Jongen PJ, Stavrakaki I, Voet B, Hoogervorst E, van Munster E, Linssen WH, et al. Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse. J Neurol. 2016;263:1641\u201351. https:\/\/doi.org\/10.1007\/s00415-016-8183-3.","journal-title":"J Neurol"},{"key":"1298_CR52","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3899\/jrheum.140111","volume":"41","author":"X Huang","year":"2014","unstructured":"Huang X, Magder LS, Petri M. Predictors of incident depression in systemic lupus erythematosus. J Rheumatol. 2014;41:1823\u201333. https:\/\/doi.org\/10.3899\/jrheum.140111.","journal-title":"J Rheumatol"},{"key":"1298_CR53","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1007\/s00415-014-7472-y","volume":"261","author":"K Nishimura","year":"2014","unstructured":"Nishimura K, Omori M, Sato E, Katsumata Y, Gono T, Kawaguchi Y, et al. New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study. J Neurol. 2014;261:2150\u20138. https:\/\/doi.org\/10.1007\/s00415-014-7472-y.","journal-title":"J Neurol"},{"key":"1298_CR54","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.neurobiolaging.2011.09.038","volume":"33","author":"ML Ancelin","year":"2012","unstructured":"Ancelin ML, Carri\u00e8re I, Helmer C, Rouaud O, Pasquier F, Berr C, et al. Steroid and nonsteroidal anti-inflammatory drugs, cognitive decline, and dementia. Neurobiol Aging. 2012;33:2082\u201390. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.09.038.","journal-title":"Neurobiol Aging"},{"key":"1298_CR55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jad.2006.09.004","volume":"99","author":"ES Brown","year":"2007","unstructured":"Brown ES, Vera E, Frol AB, Woolston DJ, Johnson B. Effects of chronic prednisone therapy on mood and memory. J Affect Disord. 2007;99:279\u201383. https:\/\/doi.org\/10.1016\/j.jad.2006.09.004.","journal-title":"J Affect Disord"},{"key":"1298_CR56","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.bjc.6603048","volume":"94","author":"J Vardy","year":"2006","unstructured":"Vardy J, Chiew KS, Galica J, Pond GR, Tannock IF. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer. 2006;94:1011\u20135. https:\/\/doi.org\/10.1038\/sj.bjc.6603048.","journal-title":"Br J Cancer"},{"key":"1298_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1212\/wnl.61.1.104","volume":"61","author":"SY Chau","year":"2003","unstructured":"Chau SY, Mok CC. Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology. 2003;61:104\u20137. https:\/\/doi.org\/10.1212\/wnl.61.1.104.","journal-title":"Neurology"},{"key":"1298_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2190\/BL97-BWFR-4QR0-CEY7","volume":"26","author":"SB Patten","year":"1996","unstructured":"Patten SB, Williams JV, Love EJ. Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics. Int J Psychiatry Med. 1996;26:15\u201324. https:\/\/doi.org\/10.2190\/BL97-BWFR-4QR0-CEY7.","journal-title":"Int J Psychiatry Med"},{"key":"1298_CR59","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/archderm.112.7.962","volume":"112","author":"FR Rosenberg","year":"1976","unstructured":"Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol. 1976;112:962\u201370. https:\/\/doi.org\/10.1001\/archderm.112.7.962.","journal-title":"Arch Dermatol"},{"key":"1298_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjp.2025.128","volume":"226","author":"T Lagerberg","year":"2025","unstructured":"Lagerberg T, Gustafsson TT, Molero Y, Forton J, Sariaslan A, Chang Z, et al. Oral glucocorticoids and risk of psychiatric and suicidal behaviour outcomes: population-based cohort study. Br J Psychiatry. 2025;226:1\u20138. https:\/\/doi.org\/10.1192\/bjp.2025.128.","journal-title":"Br J Psychiatry"},{"key":"1298_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2023.111179","volume":"167","author":"K Ogyu","year":"2023","unstructured":"Ogyu K, Mashima Y, Nishi A, Kusudo K, Kato H, Kurose S, et al. Intravenous pulse methylprednisolone and corticosteroid-induced psychiatric disorders: a retrospective study. J Psychosom Res. 2023;167:111179. https:\/\/doi.org\/10.1016\/j.jpsychores.2023.111179.","journal-title":"J Psychosom Res"},{"key":"1298_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.608149","volume":"12","author":"T Akaishi","year":"2021","unstructured":"Akaishi T, Takahashi T, Fujihara K, Misu T, Fujimori J, Takai Y, et al. Early treatment initiation with oral prednisolone for relapse prevention alleviates depression and fatigue in aquaporin-4-positive neuromyelitis optica spectrum disorder. Front Neurol. 2021;12:608149. https:\/\/doi.org\/10.3389\/fneur.2021.608149.","journal-title":"Front Neurol"},{"key":"1298_CR63","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.schres.2018.03.018","volume":"199","author":"BV Broberg","year":"2018","unstructured":"Broberg BV, Sommer IE, Benros ME, Glenth\u00f8j BY, Gasse C, K\u00f6hler-Forsberg O. Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence: a Danish nationwide study. Schizophr Res. 2018;199:116\u201322. https:\/\/doi.org\/10.1016\/j.schres.2018.03.018.","journal-title":"Schizophr Res"},{"key":"1298_CR64","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.autrev.2016.03.017","volume":"15","author":"Y Shimizu","year":"2016","unstructured":"Shimizu Y, Yasuda S, Kako Y, Nakagawa S, Kanda M, Hisada R, et al. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE. Autoimmun Rev. 2016;15:786\u201394. https:\/\/doi.org\/10.1016\/j.autrev.2016.03.017.","journal-title":"Autoimmun Rev"},{"key":"1298_CR65","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00296-012-2557-3","volume":"33","author":"M Onoda","year":"2013","unstructured":"Onoda M, Inokuma S, Arai S. Anti-SS-A (Ro) antibody is positively associated with steroid-induced psychiatric events in systemic lupus erythematosus patients. Rheumatol Int. 2013;33:1437\u201342. https:\/\/doi.org\/10.1007\/s00296-012-2557-3.","journal-title":"Rheumatol Int"},{"key":"1298_CR66","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1212\/WNL.38.10.1631","volume":"38","author":"SL Minden","year":"1988","unstructured":"Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology. 1988;38:1631\u20134.","journal-title":"Neurology"},{"key":"1298_CR67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0006-3223(89)90026-7","volume":"26","author":"P Br\u00e4unig","year":"1989","unstructured":"Br\u00e4unig P, Bleistein J, Rao ML. Suicidality and corticosteroid-induced psychosis. Biol Psychiatry. 1989;26:209\u201310. https:\/\/doi.org\/10.1016\/0006-3223(89)90026-7.","journal-title":"Biol Psychiatry"},{"key":"1298_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/921253","volume":"2013","author":"DM Youssef","year":"2013","unstructured":"Youssef DM, Abdelsalam MM, Abozeid AM, Youssef UM. Assessment of behavior abnormalities of corticosteroids in children with nephrotic syndrome. ISRN Psychiatry. 2013;2013:921253. https:\/\/doi.org\/10.1155\/2013\/921253.","journal-title":"ISRN Psychiatry"},{"key":"1298_CR69","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1158\/1078-0432.CCR-07-0902","volume":"13","author":"R Felder-Puig","year":"2007","unstructured":"Felder-Puig R, Scherzer C, Baumgartner M, Ortner M, Aschenbrenner C, Bieglmayer C, et al. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and Hodgkin\u2019s disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers. Clin Cancer Res. 2007;13:7093\u2013100. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0902.","journal-title":"Clin Cancer Res"},{"key":"1298_CR70","doi-asserted-by":"publisher","DOI":"10.1542\/peds.104.4.e51","volume":"104","author":"E Soliday","year":"1999","unstructured":"Soliday E, Grey S, Lande MB. Behavioral effects of corticosteroids in steroid-sensitive nephrotic syndrome. Pediatrics. 1999;104:e51. https:\/\/doi.org\/10.1542\/peds.104.4.e51.","journal-title":"Pediatrics"},{"key":"1298_CR71","first-page":"218","volume":"69","author":"M Nall","year":"1992","unstructured":"Nall M, Corbett M, McLoughlin J, Petrosko J, Garcia D, Karibo J. Impact of short-term oral steroid use upon children\u2019s school achievement and behavior. Ann Allergy. 1992;69:218\u201320.","journal-title":"Ann Allergy"},{"key":"1298_CR72","first-page":"414","volume":"66","author":"BG Bender","year":"1991","unstructured":"Bender BG, Lerner JA, Poland JE. Association between corticosteroids and psychologic change in hospitalized asthmatic children. Ann Allergy. 1991;66:414\u20139.","journal-title":"Ann Allergy"},{"key":"1298_CR73","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/00004583-198811000-00010","volume":"27","author":"BG Bender","year":"1988","unstructured":"Bender BG, Lerner JA, Kollasch E. Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry. 1988;27:720\u20135. https:\/\/doi.org\/10.1097\/00004583-198811000-00010.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1298_CR74","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/bjh.19610","volume":"205","author":"S Anastasopoulou","year":"2024","unstructured":"Anastasopoulou S, Swann G, Andres-Jensen L, Attarbaschi A, Barzilai-Birenboim S, Erdelyi DJ, et al. Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy: an observational Ponte di Legno Toxicity Working Group Study. Br J Haematol. 2024;205:1450\u20139. https:\/\/doi.org\/10.1111\/bjh.19610.","journal-title":"Br J Haematol"},{"key":"1298_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28847","volume":"68","author":"AC Muriel","year":"2021","unstructured":"Muriel AC, Burgers DE, Treyball AN, Vrooman LM, Adolf E, Samsel C. Risk factors for steroid-induced affective disorder in children with leukemia. Pediatr Blood Cancer. 2021;68:e28847. https:\/\/doi.org\/10.1002\/pbc.28847.","journal-title":"Pediatr Blood Cancer"},{"key":"1298_CR76","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1177\/1078155219879992","volume":"26","author":"Y Staub","year":"2020","unstructured":"Staub Y, Suga Y, Ikawa Y, Tsubouchi K, Hashimoto M, Kawagishi A, et al. Detailed assessment and risk factor analysis of corticosteroid-induced psychiatric disorders in pediatric, adolescent, and young adult patients undergoing induction or consolidation therapy for hematologic malignancy. J Oncol Pharm Pract. 2020;26:1041\u201351. https:\/\/doi.org\/10.1177\/1078155219879992.","journal-title":"J Oncol Pharm Pract"},{"key":"1298_CR77","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038489","volume":"103","author":"K Koyama","year":"2024","unstructured":"Koyama K, Ohgami A, Nawata T, Sato K, Fujinaka M, Shibuya M, et al. Serial changes in anxiety levels related to corticosteroid use: a single-center prospective study. Medicine (Baltimore). 2024;103:e38489. https:\/\/doi.org\/10.1097\/MD.0000000000038489.","journal-title":"Medicine (Baltimore)"},{"key":"1298_CR78","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.msard.2018.01.012","volume":"20","author":"L Lorefice","year":"2018","unstructured":"Lorefice L, Fenu G, Fois M, Frau J, Coghe G, Marrosu MG, et al. Pulse steroid therapy in multiple sclerosis and mood changes: an exploratory prospective study. Mult Scler Relat Disord. 2018;20:104\u20138. https:\/\/doi.org\/10.1016\/j.msard.2018.01.012.","journal-title":"Mult Scler Relat Disord"},{"key":"1298_CR79","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/jcag\/gwy023","volume":"1","author":"G Ou","year":"2018","unstructured":"Ou G, Bressler B, Galorport C, Lam E, Ko HH, Enns R, et al. Rate of corticosteroid-induced mood changes in patients with inflammatory bowel disease: a prospective study. J Can Assoc Gastroenterol. 2018;1:99\u2013106. https:\/\/doi.org\/10.1093\/jcag\/gwy023.","journal-title":"J Can Assoc Gastroenterol"},{"key":"1298_CR80","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/YIC.0000000000000122","volume":"31","author":"I Lotan","year":"2016","unstructured":"Lotan I, Fireman L, Benninger F, Weizman A, Steiner I. Psychiatric side effects of acute high-dose corticosteroid therapy in neurological conditions. Int Clin Psychopharmacol. 2016;31:224\u201331. https:\/\/doi.org\/10.1097\/YIC.0000000000000122.","journal-title":"Int Clin Psychopharmacol"},{"key":"1298_CR81","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jad.2015.08.040","volume":"187","author":"SA Morrow","year":"2015","unstructured":"Morrow SA, Barr J, Rosehart H, Ulch S. Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses. J Affect Disord. 2015;187:142\u20136. https:\/\/doi.org\/10.1016\/j.jad.2015.08.040.","journal-title":"J Affect Disord"},{"key":"1298_CR82","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0306-4530(95)00031-3","volume":"21","author":"D Naber","year":"1996","unstructured":"Naber D, Sand P, Heigl B. Psychopathological and neuropsychological effects of 8-days\u2019 corticosteroid treatment: a prospective study. Psychoneuroendocrinology. 1996;21:25\u201331. https:\/\/doi.org\/10.1016\/0306-4530(95)00031-3.","journal-title":"Psychoneuroendocrinology"},{"key":"1298_CR83","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2125.1988.tb05309.x","volume":"26","author":"CR Swinburn","year":"1988","unstructured":"Swinburn CR, Wakefield JM, Newman SP, Jones PW. Evidence of prednisolone induced mood change (\u2018steroid euphoria\u2019) in patients with chronic obstructive airways disease. Br J Clin Pharmacol. 1988;26:709\u201313. https:\/\/doi.org\/10.1111\/j.1365-2125.1988.tb05309.x.","journal-title":"Br J Clin Pharmacol"},{"key":"1298_CR84","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2190\/1h08-r84a-30vd-f5rj","volume":"15","author":"OG Cameron","year":"1985","unstructured":"Cameron OG, Addy RO, Malitz D. Effects of ACTH and prednisone on mood: incidence and time of onset. Int J Psychiatry Med. 1985;15:213\u201323. https:\/\/doi.org\/10.2190\/1h08-r84a-30vd-f5rj.","journal-title":"Int J Psychiatry Med"},{"key":"1298_CR85","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1590\/2175-8239-jbn-2021-0043","volume":"44","author":"P Singh","year":"2022","unstructured":"Singh P, Mishra OP, Upadhyay SK, Prasad R, Singh A, Abhinay A, et al. Persistence of behavioral abnormalities following corticosteroid therapy in children with initial episode of idiopathic nephrotic syndrome: a prospective longitudinal observation. Braz J Nephrol. 2022;44:58\u201367. https:\/\/doi.org\/10.1590\/2175-8239-jbn-2021-0043.","journal-title":"Braz J Nephrol"},{"key":"1298_CR86","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/pbc.23060","volume":"57","author":"CM Mrakotsky","year":"2011","unstructured":"Mrakotsky CM, Silverman LB, Dahlberg SE, Alyman MCA, Sands SA, Queally JT, et al. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. Pediatr Blood Cancer. 2011;57:492\u20138. https:\/\/doi.org\/10.1002\/pbc.23060.","journal-title":"Pediatr Blood Cancer"},{"key":"1298_CR87","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00467-003-1295-x","volume":"18","author":"AS Hall","year":"2003","unstructured":"Hall AS, Thorley G, Houtman PN. The effects of corticosteroids on behavior in children with nephrotic syndrome. Pediatr Nephrol. 2003;18:1220\u20133. https:\/\/doi.org\/10.1007\/s00467-003-1295-x.","journal-title":"Pediatr Nephrol"},{"key":"1298_CR88","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/wps.20831","volume":"20","author":"K Laugesen","year":"2021","unstructured":"Laugesen K, Farkas DK, Vestergaard M, J\u00f8rgensen JOL, Petersen I, S\u00f8rensen HT. Glucocorticoid use and risk of suicide: a Danish population-based case\u2013control study. World Psychiatry. 2021;20:142\u20133. https:\/\/doi.org\/10.1002\/wps.20831.","journal-title":"World Psychiatry"},{"key":"1298_CR89","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/070674379504000706","volume":"40","author":"SB Patten","year":"1995","unstructured":"Patten SB, Williams JV, Love EJ. A case-control study of corticosteroid exposure as a risk factor for clinically-diagnosed depressive disorders in a hospitalized population. Can J Psychiatry. 1995;40:396\u2013400. https:\/\/doi.org\/10.1177\/070674379504000706.","journal-title":"Can J Psychiatry"},{"key":"1298_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2021.100594","volume":"14","author":"S Bian","year":"2021","unstructured":"Bian S, Li L, Wang Z, Cui L, Xu Y, Guan K, et al. Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: a real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS). World Allergy Organ J. 2021;14:100594. https:\/\/doi.org\/10.1016\/j.waojou.2021.100594.","journal-title":"World Allergy Organ J"},{"key":"1298_CR91","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1365-2125.2008.03219.x","volume":"66","author":"N Tavassoli","year":"2008","unstructured":"Tavassoli N, Montastruc-Fournier J, Montastruc JL, French Association of Regional Pharmacovigilance Centres. Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses. Br J Clin Pharmacol. 2008;66:566\u20137. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03219.x.","journal-title":"Br J Clin Pharmacol"},{"key":"1298_CR92","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000118427","volume":"19","author":"RT Joffe","year":"1988","unstructured":"Joffe RT, Wolkowitz OM, Rubinow DR, Denicoff K, Tsokos G, Pillemer S. Alternate-day corticosteroid treatment, mood and plasma HVA in patients with systemic Lupus erythematosus. Neuropsychobiology. 1988;19:17\u20139. https:\/\/doi.org\/10.1159\/000118427.","journal-title":"Neuropsychobiology"},{"key":"1298_CR93","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0163-8343(88)90085-0","volume":"10","author":"RT Joffe","year":"1988","unstructured":"Joffe RT, Denicoff KD, Rubinow DR, Tsokos G, Balow JE, Pillemer SE. Mood effects of alternate-day corticosteroid therapy in patients with systemic Lupus erythematosus. Gen Hosp Psychiatry. 1988;10:56\u201360. https:\/\/doi.org\/10.1016\/0163-8343(88)90085-0.","journal-title":"Gen Hosp Psychiatry"},{"key":"1298_CR94","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/MPH.0b013e318257fdac","volume":"34","author":"CM Pound","year":"2012","unstructured":"Pound CM, Clark C, Ni A, Athale U, Lewis V, Halton JM. Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered trial. J Pediatr Hematol Oncol. 2012;34:517\u201323. https:\/\/doi.org\/10.1097\/MPH.0b013e318257fdac.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1298_CR95","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0002-7138(09)60608-7","volume":"25","author":"JC Harris","year":"1986","unstructured":"Harris JC, Carel CA, Rosenberg LA, Joshi P, Leventhal BG. Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences. J Am Acad Child Adolesc Psychiatry. 1986;25:120\u20134. https:\/\/doi.org\/10.1016\/S0002-7138(09)60608-7.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1298_CR96","doi-asserted-by":"publisher","first-page":"18459","DOI":"10.1073\/pnas.1111746108","volume":"108","author":"KA Butts","year":"2011","unstructured":"Butts KA, Weinberg J, Young AH, Phillips AG. Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function. Proc Natl Acad Sci USA. 2011;108:18459\u201364. https:\/\/doi.org\/10.1073\/pnas.1111746108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1298_CR97","doi-asserted-by":"publisher","first-page":"8461","DOI":"10.1523\/JNEUROSCI.2279-15.2016","volume":"36","author":"S Di","year":"2016","unstructured":"Di S, Itoga CA, Fisher MO, Solomonow J, Roltsch EA, Gilpin NW, et al. Acute stress suppresses synaptic inhibition and increases anxiety via endocannabinoid release in the basolateral amygdala. J Neurosci. 2016;36:8461\u201370. https:\/\/doi.org\/10.1523\/JNEUROSCI.2279-15.2016.","journal-title":"J Neurosci"},{"key":"1298_CR98","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1134\/S0006297923050012","volume":"88","author":"NV Gulyaeva","year":"2023","unstructured":"Gulyaeva NV. Glucocorticoids orchestrate adult hippocampal plasticity: growth points and translational aspects. Biochem Mosc. 2023;88:565\u201389. https:\/\/doi.org\/10.1134\/S0006297923050012.","journal-title":"Biochem Mosc"},{"key":"1298_CR99","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1532-5415.1994.tb06219.x","volume":"42","author":"KM Tornatore","year":"1994","unstructured":"Tornatore KM, Logue G, Venuto RC, Davis PJ. Pharmacokinetics of methylprednisolone in elderly and young healthy males. J Am Geriatr Soc. 1994;42:1118\u201322. https:\/\/doi.org\/10.1111\/j.1532-5415.1994.tb06219.x.","journal-title":"J Am Geriatr Soc"},{"key":"1298_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-022-03455-z","volume":"22","author":"R Orihashi","year":"2022","unstructured":"Orihashi R, Imamura Y, Yamada S, Monji A, Mizoguchi Y. Association between cortisol and aging-related hippocampus volume changes in community-dwelling older adults: a 7-year follow-up study. BMC Geriatr. 2022;22:765. https:\/\/doi.org\/10.1186\/s12877-022-03455-z.","journal-title":"BMC Geriatr"},{"key":"1298_CR101","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.mayocp.2014.01.010","volume":"89","author":"LB Drozdowicz","year":"2014","unstructured":"Drozdowicz LB, Bostwick JM. Psychiatric adverse effects of pediatric corticosteroid use. Mayo Clin Proc. 2014;89:817\u201334. https:\/\/doi.org\/10.1016\/j.mayocp.2014.01.010.","journal-title":"Mayo Clin Proc"},{"key":"1298_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.856876","volume":"14","author":"N Hansen","year":"2022","unstructured":"Hansen N, Hirschel S, Rentzsch K, Wiltfang J, Malchow B, Fitzner D. Immunotherapy with corticosteroids in anti-neural autoantibody-associated cognitive impairment: retrospective case series. Front Aging Neurosci. 2022;14:856876. https:\/\/doi.org\/10.3389\/fnagi.2022.856876.","journal-title":"Front Aging Neurosci"},{"key":"1298_CR103","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00702-022-02578-2","volume":"130","author":"N Hansen","year":"2023","unstructured":"Hansen N, Neyazi A, L\u00fcdecke D, Hasan A, Wiltfang J, Malchow B. Repositioning synthetic glucocorticoids in psychiatric disease associated with neural autoantibodies: a narrative review. J Neural Transm. 2023;130:1029\u201338. https:\/\/doi.org\/10.1007\/s00702-022-02578-2.","journal-title":"J Neural Transm"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-026-01298-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:01:53Z","timestamp":1783702913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-026-01298-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":103,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1298"],"URL":"https:\/\/doi.org\/10.1007\/s40263-026-01298-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Keisuke Kusudo, Yuki Mashima, Hideaki Yasuda, Teruomi Iyo, and Hiroyoshi Takeuchi have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests\/competing interests"}},{"value":"Not applicable. This study is a systematic review and meta-analysis of published literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study-level characteristics and risk-of-bias assessments that underpin the meta-analysis are provided in Tables\u202f2\u20139 of the ESM. The spreadsheet containing all extracted quantitative data (effect sizes, standard errors, moderators) and the R scripts used for the analyses can be obtained from the corresponding author on reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The custom R code for the three-level meta-analysis and meta-regression is available on request from the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"KK: Investigation, data curation, writing (original draft), writing (review and editing), visualization. YM: investigation, data curation, writing (original draft), writing (review and editing), visualization. HY: methodology, formal analysis, investigation, data curation, writing (original draft), writing (review and editing), visualization. TI: visualization. HT: conceptualization, methodology, writing (review and editing), supervision, project administration. All the authors have read and approved the final submitted manuscript, and agree to be accountable for the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}